Chen Shirui, Wang Tielong, Luo Tao, He Shujiao, Huang Changjun, Jia Zehua, Zhan Liqiang, Wang Dongping, Zhu Xiaofeng, Guo Zhiyong, He Xiaoshun
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Organ Donation and Transplant Immunology, Guangzhou, China.
Front Surg. 2021 Nov 19;8:753056. doi: 10.3389/fsurg.2021.753056. eCollection 2021.
Early allograft dysfunction (EAD) is correlated with poor patient or graft survival in liver transplantation. However, the power of distinct definitions of EAD in prediction of graft survival is unclear. This retrospective, single-center study reviewed data of 677 recipients undergoing orthotopic liver transplant between July 2015 and June 2020. The following EAD definitions were compared: liver graft assessment following transplantation (L-GrAFT) risk score model, early allograft failure simplified estimation score (EASE), model for early allograft function (MEAF) scoring, and Olthoff criteria. Risk factors for L-GrAFT high risk group were evaluated with univariate and multivariable logistic regression analysis. L-GrAFT had a satisfied C-statistic of 0.87 in predicting a 3-month graft survival which significantly outperformed MEAF (C-statistic = 0.78, = 0.01) and EAD (C-statistic = 0.75, < 0.001), respectively. L-GrAFT, EASE was similar to L-GrAFT, and they had no statistical significance in predicting survival. Laboratory model for end-stage liver disease score and cold ischemia time are risk factors of L-GrAFT high-risk group. L-GrAFT risk score is capable for better predicting the 3-month graft survival than the MEAF and EAD in a Chinese cohort, which might standardize assessment of early graft function and serve as a surrogate endpoint in clinical trial.
早期移植物功能障碍(EAD)与肝移植患者预后不良或移植物存活情况相关。然而,不同的EAD定义在预测移植物存活方面的效力尚不清楚。这项回顾性单中心研究回顾了2015年7月至2020年6月期间接受原位肝移植的677例受者的数据。对以下EAD定义进行了比较:移植后肝移植物评估(L-GrAFT)风险评分模型、早期移植物功能衰竭简化评估评分(EASE)、早期移植物功能模型(MEAF)评分以及奥尔特霍夫标准。采用单因素和多因素逻辑回归分析评估L-GrAFT高风险组的危险因素。L-GrAFT在预测3个月移植物存活方面的C统计量为0.87,分别显著优于MEAF(C统计量=0.78,P=0.01)和EAD(C统计量=0.75,P<0.001)。EASE与L-GrAFT相似,在预测存活方面无统计学意义。终末期肝病评分实验室模型和冷缺血时间是L-GrAFT高风险组的危险因素。在中国队列中,L-GrAFT风险评分在预测3个月移植物存活方面比MEAF和EAD更具优势,这可能会规范早期移植物功能评估,并作为临床试验中的替代终点。